Catalyst Wire Dossier Catalyst Wire Dossier

Vimseltinib

Vimseltinib · Deciphera Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Vimseltinib, covering 2025-02-24 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel) [Phase 1]

See pricing